GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Quarterly figures for GT Biopharma, Inc., with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
GT Biopharma, Inc. has filed its 10-Q within 45 to 45 days of period end across its last 8 quarters. The 10-K runs 52 to 106 days.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | — | — | -$0.12 | |
| Mar 31, 2026 |
| — |
| May 15, 2026 |
| 45 d |
| 10-Q |
| — |
| — |
| -$0.11 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Mar 2, 2026 | 61 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 · market hours | Nov 14, 2025 | 45 d | 10-Q | — | — | $1.04 | |
| Q2 2025 | Jun 30, 2025 | — | Aug 14, 2025 | 45 d | 10-Q | — | — | -$10.92 | |
| Q1 2025 | Mar 31, 2025 | — | May 15, 2025 | 45 d | 10-Q | — | — | -$0.33 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | — | Feb 21, 2025 | 52 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 14, 2024 | 45 d | 10-Q | — | — | -$1.53 | |
| Q2 2024 | Jun 30, 2024 | — | Aug 14, 2024 | 45 d | 10-Q | — | — | -$2.17 | |
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | — | — | -$1.64 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Mar 26, 2024 | 86 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 1, 2023 | 32 d | 10-Q | — | — | -$1.77 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 7, 2023 | 38 d | 10-Q | — | — | -$1.49 | |
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | — | — | -$0.21 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Mar 30, 2023 | 89 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Oct 31, 2022 | 31 d | 10-Q | — | — | -$0.22 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | -$0.10 | |
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | — | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 28, 2022 | 87 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 10, 2021 | 41 d | 10-Q | $0.00 | — | -$0.17 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 23, 2021 | 54 d | 10-Q | $0.00 | — | -$0.15 | |
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | $0.00 | — | -$1.83 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Apr 16, 2021 | 106 d | 10-K | $0.00 | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 13, 2020 | 44 d | 10-Q | $0.00 | — | -$0.64 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 14, 2020 | 45 d | 10-Q | $0.00 | — | -$4.12 | |
| Q1 2020 | Mar 31, 2020 | — | May 15, 2020 | 45 d | 10-Q | $0.00 | — | -$0.02 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | — | Mar 27, 2020 | 87 d | 10-K | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 14, 2019 | 45 d | 10-Q | — | — | -$0.51 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | — | — | -$0.05 | |
| Q1 2019 | Mar 31, 2019 | — | May 15, 2019 | 45 d | 10-Q | $0.00 | — | -$0.09 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | Mar 29, 2019 | 88 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | 45 d | 10-Q | — | — | -$4.70 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $0.00 | — | $50,117,977.00 | |
| Q1 2018 | Mar 31, 2018 | — | May 15, 2018 | 45 d | 10-Q | $0.00 | — | -$0.20 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017derived | Dec 31, 2017 | — | Mar 1, 2018 | 60 d | 10-K | $0.00 | — | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 14, 2017 | 45 d | 10-Q | $0.00 | — | -$8.15 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 11, 2017 | 42 d | 10-Q | $0.00 | — | $479,053.00 | |
| Q1 2017 | Mar 31, 2017 | — | Apr 28, 2017 | 28 d | 10-Q | $0.00 | — | -$26.36 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016derived | Dec 31, 2016 | — | Mar 31, 2017 | 90 d | 10-K | $0.00 | — | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 14, 2016 | 45 d | 10-Q | $0.00 | — | $0.13 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 10, 2016 | 41 d | 10-Q | $0.00 | −100.0% | $0.06 | |
| Q1 2016 | Mar 31, 2016 | — | May 13, 2016 | 43 d | 10-Q | $0.00 | −100.0% | $0.84 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015derived | Dec 31, 2015 | — | Mar 30, 2016 | 90 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 13, 2015 | 44 d | 10-Q | $0.00 | −100.0% | $0.71 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 14, 2015 | 45 d | 10-Q | $20.00K | −20.0% | $5.47 | |
| Q1 2015 | Mar 31, 2015 | — | May 14, 2015 | 44 d | 10-Q | $7.00K | — | -$8.61 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014derived | Dec 31, 2014 | — | Mar 31, 2015 | 90 d | 10-K | $33.00K | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Jan 8, 2015 | 100 d | 10-Q | $3.00K | −98.4% | -$0.01 | |
| Q2 2014 | Jun 30, 2014 | — | Jan 8, 2015 | 192 d | 10-Q | $25.00K | −86.3% | $0.00 | |
| Q1 2014 | Mar 31, 2014 | — | Jan 8, 2015 | 283 d | 10-Q | $0.00 | −100.0% | $0.00 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013derived | Dec 31, 2013 | — | Jan 8, 2015 | 373 d | 10-K | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Dec 17, 2014 | 443 d | 10-Q | $183.00K | +52.5% | $0.00 | |
| Q2 2013 | Jun 30, 2013 | — | Dec 12, 2014 | 530 d | 10-Q | $183.00K | +18,200.0% | $0.00 | |
| Q1 2013 | Mar 31, 2013 | — | Dec 10, 2014 | 619 d | 10-Q | $88.00K | +8,700.0% | $0.00 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012derived | Dec 31, 2012 | — | Nov 18, 2014 | 687 d | 10-K | $220.00K | +7,233.3% | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 21, 2012 | 52 d | 10-Q | $120.00K | +5,900.0% | $0.00 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 20, 2012 | 51 d | 10-Q | $1.00K | ±0.0% | -$0.01 | |
| Q1 2012 | Mar 31, 2012 | — | May 21, 2012 | 51 d | 10-Q | $1.00K | −95.0% | $0.00 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011derived | Dec 31, 2011 | — | Apr 16, 2012 | 107 d | 10-K | $3.00K | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 21, 2011 | 52 d | 10-Q | $2.00K | — | $0.00 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 22, 2011 | 53 d | 10-Q | $1.00K | — | $0.00 | |
| Q1 2011 | Mar 31, 2011 | — | May 16, 2011 | 46 d | 10-Q | $20.00K | — | -$0.01 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | Mar 31, 2011 | 90 d | 10-K | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 12, 2010 | 43 d | 10-Q | $0.00 | — | $0.01 | |
| Q2 2010 | Jun 30, 2010 | — | Aug 16, 2010 | 47 d | 10-Q | $0.00 | — | $0.00 | |
